Clinical Trial Update: Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft [Phase 2, Phase 3]

View source ↗

Summary

Remodulin (treprostinil) was studied in Phase 2/3 trials for critical limb ischemia after vein bypass grafts in patients with peripheral artery disease, but the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease

Drugs mentioned

• Remodulin (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Peripheral Vascular Disease | Phase 2, Phase 3 | Status: TERMINATED